LDX should continue on from yesterday's gains, after releasing the convertible note holders.
Their product FebriX is on the verge of a US launch after recent FDA approval, multi billion dollar market and one of the best tests to determine if a patient has a virus or a bacterial infection. This produces a positive treatment outcome with extremely high accuracy.
Worth a look, could be few DTs coming with this one.
